56 Pages Posted: 1 Dec 2013 Last revised: 10 Dec 2013
Date Written: December 3, 2013
We present a dialogue on Funding Costs and Counterparty Credit Risk modeling, inclusive of collateral, wrong way risk, gap risk and possible Central Clearing implementation through CCPs. This framework is important following the fact that derivatives valuation and risk analysis has moved from exotic derivatives managed on simple single asset classes to simple derivatives embedding the new or previously neglected types of complex and interconnected nonlinear risks we address here. This dialogue is the continuation of the "Counterparty Risk, Collateral and Funding FAQ" by Brigo (2011). In this dialogue we focus more on funding costs for the hedging strategy of a portfolio of trades, on the non-linearities emerging from assuming borrowing and lending rates to be different, on the resulting aggregation-dependent valuation process and its operational challenges, on the implications of the onset of central clearing, on the macro and micro effects on valuation and risk of the onset of CCPs, on initial and variation margins impact on valuation, and on multiple discount curves. Through questions and answers (Q&A) between a senior expert and a junior colleague, and by referring to the growing body of literature on the subject, we present a unified view of valuation (and risk) that takes all such aspects into account.
Keywords: CCPs, Central Clearing, CSA, Credit Risk, Collateral, Funding Costs Valuation, Re-hypothecation, CVA, Closeout, Netting, WWR, Gap-Risk, Initial Margin, Variation Margin, Multiple Discount Curves, FVA
JEL Classification: G13, G33, H63
Suggested Citation: Suggested Citation
Brigo, Damiano and Pallavicini, Andrea, CCPs, Central Clearing, CSA, Credit Collateral and Funding Costs Valuation FAQ: Re-Hypothecation, CVA, Closeout, Netting, WWR, Gap-Risk, Initial and Variation Margins, Multiple Discount Curves, FVA? (December 3, 2013). Available at SSRN: https://ssrn.com/abstract=2361697 or http://dx.doi.org/10.2139/ssrn.2361697